Panama vs Peru: Average cost of multi drug-resistant tuberculosis treatment
Panama
572 constant 2022 US$
in 2024
Peru
570 constant 2022 US$
in 2024
Panama rank
74th
Peru rank
75th
Average cost of multi drug-resistant tuberculosis treatment over time
- Panama
- Peru
How they compare
Panama currently reports 572 constant 2022 US$ against 570 constant 2022 US$ in Peru, a difference of 2 constant 2022 US$.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Panama ahead.
Panama ranks 74th and Peru ranks 75th of 92 countries.
Panama has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Panama | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5,436 constant 2022 US$ | 1,374 constant 2022 US$ | 4,063 constant 2022 US$ | Panama |
| 2020s | 1,288 constant 2022 US$ | 1,102 constant 2022 US$ | 186.33 constant 2022 US$ | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Panama or Peru?
- Panama, at 572 constant 2022 US$ against 570 constant 2022 US$ in Peru as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Panama and Peru?
- 2 constant 2022 US$, with Panama ahead.
- How many years of comparable data are there for Panama and Peru?
- 5 years are reported by both, from 2017 to 2024.
- How do Panama and Peru rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Panama ranks 74th and Peru ranks 75th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.